An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality

Marjuki, Henju; Mishin, Vasiliy P.; Chesnokov, Anton P.; De La Cruz, Juan A.; Fry, Alicia M.; Villanueva, Julie; Gubareva, Larisa V.

doi:10.1093/infdis/jiu105

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality

Published Date:

Feb 25 2014

Publisher's site:

http://dx.doi.org/10.1093/infdis/jiu105 New Site Icon

Source:

J Infect Dis. 2014; 210(3):435-440.

[PDF-816.01 KB]

Details:

Personal Authors:

Marjuki, Henju ; Mishin, Vasiliy P. ; Chesnokov, Anton P. ; De La Cruz, Juan A. ; Fry, Alicia M. ; ... More ▼

Keywords:

[+]

Description:

Human infections caused by avian influenza A virus type subtype H7N9 have been associated with substantial morbidity and mortality. Emergence of virus variants carrying markers of decreased susceptibility to neuraminidase inhibitors was reported. Here we show that DAS181 (Fludase), an antiviral drug with sialidase activity, potently inhibited replication of wild-type influenza A(H7N9) and its oseltamivir-resistant R292K variants in mice. A once-daily administration initiated early after lethal infection hampered body weight loss and completely protected mice from lethality. We observed a time-dependent effect for 24-72-hour delayed DAS181 treatments on morbidity and mortality. The results warrant further investigation of DAS181 for influenza treatment.

Document Type:

Journal Article

Collection(s):

CDC Public Access

Supporting Files:

supp_210_3_435__index.html	text/html
jiu105.nxml	text/plain
jiu10501.gif	image/gif
jiu10501.jpg	image/jpeg
jiu10502.gif	image/gif
jiu10502.jpg	image/jpeg
license.txt	text/plain

No Related Documents.

You May Also Like:

Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Isolated from Poultry, Vietnam, 2009–2011

Personal Author:

Nguyen, Ha T.; Nguyen, Tung; Mishin, Vasiliy P.; Sleeman, Katrina; Balish, Amanda; Jones, Joyce; Creanga, Adrian; Marjuki, Henju; Uyeki, Timothy M.; Nguyen, Dang H.; Nguyen, Diep T.; Do, Hoa T.; Klimov, Alexander I.; Davis, Charles T.; Gubareva, Larisa V.;

Published:

Dec 2013

Source:

Emerg Infect Dis. 19(12):1963-1971.

Description:

We assessed drug susceptibilities of 125 avian influenza A(H5N1) viruses isolated from poultry in Vietnam during 2009-2011. Of 25 clade 1.1 viruses, all possessed a marker of resistance to M2 blockers amantadine and rimantadine; 24 were inhibited by ...

File Type:

[PDF - 635.07 KB]
Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins

Personal Author:

Marjuki, Henju; Mishin, Vasiliy P.; Chai, Ning; Tan, Man-Wah; Newton, Elizabeth M.; Tegeris, John; Erlandson, Karl; Willis, Melissa; Jones, Joyce; Davis, Todd; Stevens, James; Gubareva, Larisa V.;

Published:

Nov 14 2016

Source:

J Virol. 2016; 90(23):10446-10458.

Description:

The pandemic threat posed by emerging zoonotic influenza A viruses necessitates development of antiviral agents effective against various antigenic subtypes. Human monoclonal antibody (hMAb) targeting the hemagglutinin (HA) stalk offers a promising a...

File Type:

[PDF - 3.28 MB]
Transcriptomic Characterization of the Novel Avian-Origin Influenza A (H7N9) Virus: Specific Host Response and Responses Intermediate between Avian (H5N1 and H7N7) and Human (H3N2) Viruses and Implications for Treatment Options

Personal Author:

Josset, Laurence; Zeng, Hui; Kelly, Sara M.; Tumpey, Terrence M.; Katze, Michael G.;

Published:

Feb 04 2014

Source:

mBio. 2014; 5(1).

Description:

A novel avian-origin H7N9 influenza A virus (IAV) emerged in China in 2013, causing mild to lethal human respiratory infections. H7N9 originated with multiple reassortment events between avian viruses and carries genetic markers of human adaptation. ...

File Type:

[PDF - 2.64 MB]
RIG-I ligand enhances the immunogenicity of recombinant H7 HA protein

Personal Author:

Cao, Weiping; Liepkalns, Justine S.; Kamal, Ram P.; Reber, Adrian J.; Kim, Jin Hyang; Hofstetter, Amelia R.; Amoah, Samuel; Stevens, James; Ranjan, Priya; Gangappa, Shivaprakash; York, Ian A.; Sambhara, Suryaprakash;

Published:

2016 Jun-Jul

Source:

Cell Immunol. 304-305:55-58.

Description:

Avian H7N9 influenza virus infection with fatal outcomes continues to pose a pandemic threat and highly immunogenic vaccines are urgently needed. In this report we show that baculovirus-derived recombinant H7 hemagglutinin protein, when delivered wit...

File Type:

[PDF - 960.70 KB]
DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective Against H5N1 Challenge Infection in Mice

Personal Author:

Epstein, Suzanne L.; Tumpey, Terrence M.; Misplon, Julia A.; Lo, Chia-Yun; Cooper, Lynn A.; Subbarao, Kanta; Renshaw, Mary; Sambhara, Suryaprakash; Katz, Jacqueline M.;

Published:

Aug 2002

Source:

Emerg Infect Dis. 8(8):796-801.

Description:

Influenza vaccination practice, which is based on neutralizing antibodies, requires being able to predict which viral strains will be circulating. If an unexpected strain, as in the 1997 H5N1 Hong Kong outbreak, or even a pandemic emerges, appropriat...

File Type:

[PDF - 297.44 KB]